Abstract:
Quality of Life (QOL) instruments are increasingly being used in multinational research and clinical practice.
More than 20 years of research have led a consensus on the definition of QOL as a multidimensional concept that detects at least four health-related domains (physical, social, psychological/emotional functions, and financial). These domains, not directly linked to disability or impairment, are considered highly important by the patients. These assertions are particularly appropriate in patients affected by multiple sclerosis (MS), who are less concerned than their clinicians about physical disability in their illness.
A large number of studies have demonstrated that patients with MS have poorer QOL than that of the general population.
Predictors of QOL in MS are distinguished between clinical and socio-demographic variables. Clinical predictors include the phenotype, disease duration, disability, depression, fatigue, cognitive impairment, bladder dysfunction, sexual and bowel disturbances, pain, and sleep disturbances. Age, gender, employment status, and education level (employment status and education in MS people) have been identified as socio-demographic variables.
In this review, we have tried to target attention on the different issues of QOL in MS –definition, measurement, relationship with the disease, and effects of treatment. As physicians we are firmly convinced that it is useful to incorporate QOL measures in clinical practice.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- DMDs:
-
disease modifying drugs
- EDSS:
- HRQOL:
-
health-related quality of life
- MAUS:
-
multiattribute utility scale
- MDD:
-
major depressive disorders
- MS:
-
multiple sclerosis
- MSQOL 54:
-
multiple sclerosis quality of life-54 instrument
- PPMS:
-
primary-progressive multiple sclerosis
- QALYs:
-
quality-adjusted life-years
- QLI:
-
quality of life index
- QOL:
-
quality of life
- RRMS:
-
relapsing–remitting multiple sclerosis
- SEIDWQOL:
-
schedule for the evaluation of individual QOL – direct weighting
- SF 36:
-
short form health survey questionnaire
- SPMS:
-
secondary-progressive multiple sclerosis
- WHO:
-
World Health Organization
References
Aronson KJ. (2007). Neurology. 49: 74–80.
Canam C, Acorn S. (1999). Rehabil Nurs. 24: 192–196.
Chang CH, Cella D, Fernandez O, Luque G, DeCastro P, deAndres C, Casanova B . et al. (2002). Mult Scler. 8: 527–531.
Chwastiak L, et al. (2002). Am J Psychiatry159: 1862–1868.
DasGupta R, Fowler CJ. (2003). Drugs. 63: 153–166.
Ferrans C, Powers M. (1985). ANS Adv Nurs Sci. 8: 15–24.
Freeman JA, Langdon DW, Hobart JC, Thompson AJ. (1999). Neurology. 52: 50–66.
Gold SM, Schulz H, Mönch A, Schulz KH, Heesen C. (2003). Mult Scler. 9(4): 404–410.
Gruenewald DA, Higginson IJ, Vivat B, Edmonds P, Burman RE. (2004). Mult Scler. 10: 690–725.
Guarnaccia JB, Aslan M, O’Connor TZ, Hope MA, Kazis L, Kashner CM, Booss J. (2006). J Rehab Res Dev. 1: 35–44.
Heckman-Stone C, Stone C. (2001). J Pain. 2: 205–208.
Hermann BP, et al. (1996). Epilepsy Res. 25: 113–118.
Janardhan V, Bakshi R. (2000). Arch Neurol. 57: 1485–1491.
Janardhan V, Bakshi R. (2002). J Neurol Sci 205: 51–58.
Janssens ACJW, van Doorn PA, deBoer JB, Kalkers NF, van der Mechè FGA, Passchier J, Hintzen RQ. (2003). Mult Scler. 9(4): 397–403.
Khan F, Pallant J. (2007). J Pain. 8: 614–623.
Khan F, Pallant J, Brand C. (2007). Disab and Rehabil. 16: 1241–1250.
Lazarus R, Folkman S. (1984). Stress, Appraisal and Coping. Springer, New York.
Lily O, McFadden E, Hensor E, Johnson M, Ford H. (2006). Mult Scler. 12(6): 808–813.
Lobentanz IS, Asenbaum S, Vass K, Sauter C, Klosch G, Kollegger H, Kristoferitsch W, Zeitlhofer J. (2004). Acta Neurol Scand. 110: 6–13.
Miller A, Dishon S. (2006). Qual Life Res. 15: 259–271.
Myers JA, McPherson KM, Taylor WJ, Weatherall M, Mc Naugthon HK. (2003). Clin Rehabil. 17: 209–215.
Nortvedt MW, Riise T, Frugard J, Mohn J, Bakke A, Skar AB, Nyland H, Glad SB, Myhr KM. (2007). Mult Scler. 13: 106–112.
Nortvedt MW, Riise T, Myhr KM, Bakke A, Landtblom AM, Nyland HI. (2001). Mult Scler. 7: 231–235.
Orme M, Kerrigan J, tyas D, Russel N, Nixon R. (2007). Value Health : 10(1)54–60.
Patti F. (2002). The Health related quality of life of patients with relapsing-remitting multiple sclerosis. An Italian longitudinal prospective multicenter study. Paper Presented to European Neurologic Congress, Berlin, June 22–26.
Patti F, Amato MP, Battaglia MA, Pitaro M, Russo P, Solaro C, Trojano M. (2007). Mult Scler. 13: 412–419.
Patti F, Cacopardo M, Palermo F, Ciancio MR, Lopes R, Restivo D, Reggio A. (2003). J Neuol Sci. 211: 55–62.
Patti F, Ciancio MR, Cacopardo M, Reggio E, Fiorilla T, Palermo F, Reggio A, Thompson AJ. (2003). J Neurol 250: 861–866.
Patti F, Pozzilli C, Montanari E, Pappalardo A, Piazza A, Levi E. (2007). Mult Scler. 13: 783–791.
Patti F, Russo PL, Pappalardo A, Macchia F, Civalleri L, Paolillo A. (2007). J Neurol Sci. 252: 121–129.
Pfennings L, Cohen L, Ader H, Polman C, Lankhorst G, Smits R. (1999). J Neurol. 246: 587–591.
Pittock SJ, Mayr WT, McClelland RL, Jorgensen NW, Weigand SD, Noseworthy JH, Rodriguez M. (2004). Arch Neurol. 61: 679–685.
Quarto G, Antorino R, Gallo A, De Sio M, D’Armiento M, Perdonà S, Damiano R. (2007). Int Urogynecol. 18: 189–194.
Rao SM. (1997). Neuropsychological aspects of multiple sclerosis. In: Raine CS, McFarland HF, Toutellotte WW (ed.) Multiple Sclerosis: Clinical and Pathogenetic Basis. Chapman&Hall, London, England, pp. 357–62.
Rothwell PM, McDowell Z, Wong CK, Dorman PJ. (1997). BMJ. 314: 1580–1583.
Simioni S, Ruffieux C, Bruggimann F, Annoni M, Schluep M. (2007). Swiss Med Wkly. 137: 496–501.
Solari A, Filippini G, Mendozzi L, Ghezzi A, Cifani S, Barbieri E. (1999). J Neurol Neurosurg Psych. 67: 158–162.
Svendson KB, Jensen TS, Overvad K, Hansen HJ, Koch-Henderson N, Bach FW. (2003). Arch Neurol. 60: 1089–1094.
Vickery BG, Hays RD, Harooni R, Myers LW, Ellison GW. (1995). Qual Life Res. 4(3): 187–206.
McCabe MP, McKern S. (2002). J Clin Psychol Med Settings. 9: 287–295.
Jean VM, Beatty WW, Paul RH. (1999). Clin Psycho. 55: 21–26.
Montel SR, Burgener C. (2007). Mult Scler. 13: 393–401.
Motl RW, Gosney JL. (2007). Mult Scler 00: 1–7.
Petajan JH, Gappmaier E, White AT, Spencer MK, Mino L, Hicks RW. (1996).Ann Neurol. 39(4): 432–441.
Rice GP, Oger J, Duquette P, Francis GS, Belanger M, laplante S, Grenier JF. (1999). Can J Neurol Sci. 26 (4):276–282.
Riduck RA, Miller D, Hass S, Hutchinson M, Calabresi PA, Confravreux C, Galetta SL, Giovannoni G, Havrdova E, Kappos L, Lublin FD, Miller DH, o’Connor PW, Philips JT, Polman CH, Radue EW, Stuart WH, Wajgt A, Weinstock-Guttmann B, Wynn DR, Lynn F, Panzara MA. (2007). Ann Neurol. 62: 335–346.
Romberg A, Virtanen A, Ruutiainen J. (2005). J Neurol. 252: 839–845.
Schwartz CE, Coulthard-Morris L, Cole B, Vollmer T. (1997). Arch Neurol. 54: 1475–1480.
Simone IL, Ceccarelli A, Tortorella C, Bellacosa A, Pellegrini F, Plasmati I, De Caro MF, Lopez M, Girolamo F, Livrea P. (2006). Health Qual Life Outcome. 4: 96.
Solari A, Filippini G, Gasco P, Colla L, Salmaggi A, La Mantia L, Farinotti M, Eoli M, Mendozzi L. (1999). Neurology 52: 57.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media LLC
About this entry
Cite this entry
Patti, F., Pappalardo, A. (2010). Quality of Life in Patients Affected by Multiple Sclerosis: A Systematic Review. In: Preedy, V.R., Watson, R.R. (eds) Handbook of Disease Burdens and Quality of Life Measures. Springer, New York, NY. https://doi.org/10.1007/978-0-387-78665-0_218
Download citation
DOI: https://doi.org/10.1007/978-0-387-78665-0_218
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-78664-3
Online ISBN: 978-0-387-78665-0
eBook Packages: MedicineReference Module Medicine